Australia: Drug users targeted in bid to stop hep C transmission

Injecting drug users will be offered a breakthrough treatment for hepatitis C as part of a Melbourne study to assess whether treating them can reduce transmission of the virus in the community.

The combination treatment of ledipasvir and sofosbuvir is part of a promising new generation of direct-acting antiviral drugs, which target the protein that makes hepatitis C and stops it from replicating.

They have not been widely available outside clinical trials to date in Australia due to their high cost.

Read more....

Labels: , , ,